Medical marijuana advocates want drug reclassified

October 16, 2012 by Frederic J. Frommer

(AP)—A federal appeals court in Washington is considering whether marijuana should be reclassified from its current status as a dangerous drug with no accepted medical use.

Last year, the rejected a petition by medical marijuana advocates to change the classification—thus keeping marijuana in the same category as drugs such as heroin. The DEA concluded that there wasn't a consensus of medical opinion on using marijuana for medical purposes.

Advocates want the U.S. for the District of Columbia Circuit to force the agency to hold a hearing and conduct findings based on the scientific record.

A lawyer for the advocates told the judges on Tuesday that the DEA has misapplied the law. A government lawyer urged the court to deny the request.

Explore further: Federal government says marijuana has no accepted medical use

shares

Related Stories

Federal government says marijuana has no accepted medical use

July 13, 2011
Marijuana has been approved by many states and the nation's capital to treat a range of illnesses, but the federal government has ruled that it has no accepted medical use and should remain classified as a dangerous drug ...

US governors seek federal marijuana clearance

December 1, 2011
A pair of US governors have filed a petition asking the US federal government to allow wider use of medical marijuana by authorizing doctors to prescribe it and pharmacies to provide it.

Arkansas court upholds medical marijuana proposal

September 27, 2012
(AP)—The Arkansas Supreme Court upheld a proposed ballot measure Thursday that, if successful, would make the state the first in the more conservative southern U.S. to legalize medical marijuana.

Recommended for you

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

Opioids overused in migraine treatment, regardless of race, study finds

August 17, 2017
African-Americans are more likely to experience debilitating migraine headaches than whites, but a new study probing the issue found no evidence of racial disparities in treatment practices.

Finding better ways to reduce serious drug side effects

August 14, 2017
Many of the medicines we depend on to treat disease—and even to save our lives—pose potentially serious risks along with their benefits. Data from the U.S. Centers for Disease Control and Prevention indicate that about ...

Ultrasound-triggered liposomes for on-demand, local anesthesia

August 10, 2017
Researchers at Boston Children's Hospital have found a new way to non-invasively relieve pain at local sites in the body; such systems could one day improve pain management by replacing addictive opioids and short-lasting ...

Independent pharmacies and online coupons help patients save money on drugs

August 8, 2017
Uninsured patients or those with limited prescription drug coverage can save significant money by buying their drugs at independent pharmacies instead of big box, grocery or chain drug stores and by using discount coupons, ...

New study generates more accurate estimates of state opioid and heroin fatalities

August 7, 2017
Although opioid and heroin deaths have been rising dramatically in the U.S., the magnitude of the epidemic varies from state to state, as does the relative proportion of opioid vs heroin poisonings. Further complicating the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.